POLR2H: A Potential Drug Target and Biomarker (G5437)

Target Name: POLR2H

NCBI ID: G5437

POLR2H

POLR2H: A Potential Drug Target and Biomarker

POLR2H is a gene that encodes a protein involved in the repair of DNA damage in cells. Mutations in the POLR2H gene have been linked to various genetic disorders, including leukemia, and have also been associated with an increased risk of DNA damage. As a result, targeting the function of this gene has the potential to lead to new treatments for a range of diseases.

The Pol DNA Damage Response

DNA damage is a critical process that enables cells to maintain genetic stability and repair any DNA that has become damaged. When DNA is damaged, the cell's repair machinery is activated to attempt to repair the damage. However, there are situations where the repair process fails to occur or is not efficient enough to prevent the damage from having a negative impact on the cell.

One of the key components of the DNA damage response is the Pol DNA damage repair complex. This complex consists of the protein Pol and several smaller proteins that work together to repair damaged DNA. Pol is the core protein of the complex and is responsible for interacting with the damaged DNA and guiding the repair process.

POLR2H Mutations

Mutations in the POLR2H gene have been linked to various genetic disorders, including leukemia. These mutations can occur spontaneously or can be inherited from an individual. Some of the most well-known mutations associated with POLR2H include missense mutations, which result in changes to the structure and/or function of the protein, and splice variants, which occur when a specific DNA sequence is missed during the process of gene editing.

The link between POLR2H mutations and cancer is still being explored, but it is clear that these mutations can have a significant impact on the function of the Pol DNA damage repair complex. Studies have shown that missense mutations can alter the stability and activity of the Pol protein, leading to a failure in DNA repair and an increased risk of DNA damage.

Targeting PolR2H

Targeting PolR2H could be a promising strategy for treating a range of diseases that are caused by DNA damage. By inhibiting the activity of the Pol DNA damage repair complex, researchers could reduce the risk of DNA damage and potentially prevent the development of cancer.

One approach to targeting PolR2H is to develop drugs that specifically inhibit the activity of the protein. These drugs could be used to treat a variety of diseases, including cancer, where the DNA damage caused by mutations in the PolR2H gene can lead to the development of cancer.

Another approach to targeting PolR2H is to use drugs that modify the activity of the Pol DNA damage repair complex. For example, researchers could develop drugs that bind to specific parts of the Pol protein and prevent it from interacting with the damaged DNA. This could result in a reduction in the repair process and an increase in the risk of DNA damage.

Conclusion

POLR2H is a gene that has the potential to be a drug target and biomarker for a range of diseases. The Pol DNA damage repair complex is a critical component of the cell's immune system, and mutations in the PolR2H gene have been linked to various genetic disorders, including leukemia. Targeting the function of this gene could lead to new treatments for a variety of diseases. Further research is needed to fully understand the impact of PolR2H mutations on the DNA damage response and to explore the potential of targeting this gene for therapeutic purposes.

Protein Name: RNA Polymerase II, I And III Subunit H

Functions: DNA-dependent RNA polymerase catalyzes the transcription of DNA into RNA using the four ribonucleoside triphosphates as substrates. Common component of RNA polymerases I, II and III which synthesize ribosomal RNA precursors, mRNA precursors and many functional non-coding RNAs, and small RNAs, such as 5S rRNA and tRNAs, respectively

The "POLR2H Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about POLR2H comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets